CORD-19:f20c8063e9b843c787707e5fc938200b3fd14ebf / 38604-38969 JSONTXT

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T229","span":{"begin":0,"end":365},"obj":"Sentence"}],"text":"Will it be useful to provide participants with health promotion materials advocating immunisation before the MG? • How can risks from crowding, limited access to sanitation or infection control be addressed? • What access will participants have to early health care intervention? • Can participants be isolated if infectious, or quarantined if exposed to infection?"}

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T229","span":{"begin":0,"end":365},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Will it be useful to provide participants with health promotion materials advocating immunisation before the MG? • How can risks from crowding, limited access to sanitation or infection control be addressed? • What access will participants have to early health care intervention? • Can participants be isolated if infectious, or quarantined if exposed to infection?"}

{"project":"Epistemic_Statements","denotations":[{"id":"T142","span":{"begin":113,"end":207},"obj":"Epistemic_statement"}],"text":"Will it be useful to provide participants with health promotion materials advocating immunisation before the MG? • How can risks from crowding, limited access to sanitation or infection control be addressed? • What access will participants have to early health care intervention? • Can participants be isolated if infectious, or quarantined if exposed to infection?"}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T19","span":{"begin":176,"end":185},"obj":"Disease"},{"id":"T20","span":{"begin":314,"end":324},"obj":"Disease"},{"id":"T21","span":{"begin":355,"end":364},"obj":"Disease"},{"id":"T15850","span":{"begin":176,"end":185},"obj":"Disease"},{"id":"T82037","span":{"begin":314,"end":324},"obj":"Disease"},{"id":"T49802","span":{"begin":355,"end":364},"obj":"Disease"}],"attributes":[{"id":"A19","pred":"mondo_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A20","pred":"mondo_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A21","pred":"mondo_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A83967","pred":"mondo_id","subj":"T15850","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A97600","pred":"mondo_id","subj":"T82037","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A90606","pred":"mondo_id","subj":"T49802","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Will it be useful to provide participants with health promotion materials advocating immunisation before the MG? • How can risks from crowding, limited access to sanitation or infection control be addressed? • What access will participants have to early health care intervention? • Can participants be isolated if infectious, or quarantined if exposed to infection?"}